Skip to content

Predisposing Factors and Prevalence of Pericardial Diseases Among ESRD Patients Who Are Admitted in Critical Care Medicine Unit in Assuit University Hospital

Predisposing Factors and Prevalence of Pericardial Diseases Among ESRD Patients Who Are Admitted in Critical Care Medicine Unit in Assuit University Hospital

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06761872
Enrollment
200
Registered
2025-01-07
Start date
2025-02-25
Completion date
2026-02-25
Last updated
2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pericardial Disease

Brief summary

The main objectives of this observational study are: 1. Provide reliable data on the prevalence of pericardial diseases, pericardial effusion, constrictive pericarditis and its predisposing factors among ESRD patients, undergoing long-term dialysis. 2. Detect the predisposing factors that could contribute to pericardial effusion amount and severity. Participants (or their designated contact persons) will be contacted over the phone for either a telephone interview or a follow-up visit in the outpatient clinics, whatever feasible and possible.

Detailed description

* Inclusion Criteria: Patients with ESRD with a GFR \<10 cc/min admitted to the internal medicine department nephrology unit or undergoing regular hemodialysis. * Exclusion Criteria: Patients presented with non-uremic pericarditis such as intra-thoracic malignancy, injury (thoracic, oesophageal, and iatrogenic trauma), pulmonary TB, autoimmune diseases, history suggestive of recent viral infection, myxedema, and severe HF. * Study tools: 1. Demographic data (age, sex, and comorbidities). 2. Clinical data including (The etiology of ESRD). (History of stitching anterior chest pain worse on inspiration, audible friction rub, and raised JVP). (Muffled heart sounds, ascites, and lower limb edema). 3. ECG for signs of pericarditis, such as concave ST segment elevation in all leads, and signs of tamponade, such as low-voltage complexes with electrical alternates. 4. Doppler echocardiography by Phillips HD 11: for detection of amount and severity of pericardial effusion. The severity was defined as Small (10 \< mm echo-free space behind the left ventricle). Moderate (10-20 mm, echo-free space behind the left ventricle and in front of the right ventricle in less than 1 cm). Large (\>20 mm which was the mentioned finding in addition to a right-sided atrial collapse). 5. Echocardiography in constrictive pericarditis shows the presence of small left ventricular dimensions with preserved systolic function, impaired diastolic function, dilated atria, abrupt termination of diastolic filling, interventricular septal bounce expiratory diastolic flow reversal in hepatic veins and tissue doppler of the medial mitral annulus is more than lateral. 6. Serum calcium and phosphorus concentrations and creatinine levels in both serum and urine were elevated. Serum lipid profile, serum albumin, hormone tests such as thyroid and parathyroid along with complete blood count.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with ESRD with a GFR \<10 cc/min are admitted to the internal medicine department nephrology unit or undergoing regular hemodialysis.

Exclusion criteria

* Patients presented with non-uremic pericarditis such as intra-thoracic malignancy, injury (thoracic, oesophageal, and iatrogenic trauma), pulmonary TB, autoimmune diseases, history suggestive of recent viral infection, myxedema, and severe HF.

Design outcomes

Primary

MeasureTime frameDescription
Detection of variable pericardial diseases in patients with ESRD.1 yearvariable pericardial diseases in patients with ESRD.

Secondary

MeasureTime frameDescription
Detection of predisposing factors of pericardial effusion.1 yearpredisposing factors of pericardial effusion.

Contacts

Primary ContactHossam Amgad Elsayed, resident physician
doc.hos17@icloud.com2001024113331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026